Ischemic Stroke Clinical Trial
Official title:
Predictors Of Stroke Outcome In Children Admitted To Assiut University Children Hospital
Stroke can be defined as an abrupt loss of brain function that is caused by decreased
cerebral blood flow.
Stroke can occur at all stages of life, but presentation is variable depending on age,
involved artery, and underlying risk factors.
Introduction Stroke can be defined as an abrupt loss of brain function that is caused by
decreased cerebral blood flow.
Stroke can occur at all stages of life, but presentation is variable depending on age,
involved artery, and underlying risk factors.
Younger children usually present with non specific symptoms such as seizures and altered
mental status, especially those younger than 1 year, whereas older children present with
focal neurologic deficits such as hemiplegia.(Rosa M et al ., 2016) Types pediatric stroke
can be divided into ischemic and hemorrhagic stroke. Ischemic stroke is defined as focal
damage to an area of brain tissue within a vascular territory due to loss of blood flow or
oxygenation. It differs from diffuse hypoxic-ischemic injury in its mechanisms and
distribution. Ischemic stroke, which represents 55% of pediatric strokes, can be subdivided
into injuries caused by arterial ischemic stroke (AIS), which is due to loss of arterial
flow, or venous infarction, which is due to loss of flow in a draining cerebral vein or
venous sinus. Cerebral sinovenous thrombosis (CSVT), which involves obstruction by clot of a
major venous sinus draining the brain parenchyma, can lead to infarcted brain parenchyma;
Hemorrhagic stroke includes spontaneous hemorrhage within the brain parenchyma
(intraparenchymal hemorrhage) and spontaneous (nontraumatic) subarachnoid hemorrhage. (Miya E
et al.,2016) Risk factors Risk factors for stroke in children differ from those in adults.
Adult risk factors are centered mainly on obstructive atherosclerotic, arteriopathies,
cardiovascular disease, and arrhythmias, which are seldom found as risk factors in children.
Stroke in children occurs primarily through 2 mechanisms, ischemic and hemorrhagic.
The most common cause of ischemic stroke is thrombotic, which occurs more commonly in
children, representing 30% to 60% of cases. Although less common in children, hemorrhagic
stroke is mainly caused by arteriovenous malformation.1 Studies such as the International
Pediatric Stroke Study (IPSS) have reported systemic risk factors for pediatric stroke
including sickle cell disease, cardiac disorders, trauma, and major infections such as
meningitis, sepsis, and encephalitis, but in most cases, no systemic disease was found.(Rose
M et al ., 2015) &(Simma B et al., 2013) Outcome of stroke Outcome of arterial ischemic
stroke (AIS) in children is considered more favorable than in adults due to the better brain
plasticity in children. However, several studies showed that more than half of survivors of
childhood AIS have long-term physical disabilities and cognitive impairment. (Studer M et al
.,2014) Although stroke etiolog and risk factors were different, stroke severity and clinical
outcomes were similar (Bigi S et al .,2011) younger age at stroke is associated with poorer
intellectual outcome and a broader spectrum of dysfunctions across multiple
neuropsychological domains.(Allman C et al.,2013) Further, children with combined cortical
and subcortical lesions have overall poorer cognitive outcome,(Westmacott R et al,.2010)
larger lesion size negatively influences cognitive and functional outcome, possibly due to
disruption of more neural network connections, adversely affecting functional brain
organization.(Long B et al., 2011).
Regarding lesion laterality, controversial reports exist concerning the effect of lesion
laterality on neuropsychological outcome. In addition, persistent seizures and persistent NI
such as hemiplegia/paresis or visual field deficits also negatively influence
neuropsychological and functional outcome. . (Allman C et al.,2013) NeuroImaging Brain
magnetic resonance imaging (MRI) as more sensitive than computed tomography (CT) in diagnosis
and detection of pediatric stroke. Head CT without contrast is the study of choice for
identifying acute hemorrhage but may be normal in the cases of ischemic stroke in the first
12 to 24 hours after the event .( Alberts MJ et al., 2011)& (Elbers J et al.,2015) Therefore,
MRI is a more sensitive modality for stroke including AIS, vascular malformations, and
central nervous system inflammatory changes. Non contrast CT used for the detection of brain
ischemia is more sensitive after the initial 24 hours.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |